Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-02-01
2005-02-01
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S021800, C514S012200, C514S002600, C514S008100, C530S350000, C530S300000, C530S356000
Reexamination Certificate
active
06849606
ABSTRACT:
A method and composition are provided for inducing or enhancing chondrogenesis in vivo or in vitro. The method is performed by exposing the cells in vitro or in vivo to an extracellular matrix comprising of type I collagen, type II collagen or a mixture of type I collagen or type II collagen and hyaluronate and further containing GDF-5.
REFERENCES:
patent: 4703108 (1987-10-01), Silver et al.
patent: 4975526 (1990-12-01), Kuberasampath et al.
patent: 5055298 (1991-10-01), Kludas
patent: 5118667 (1992-06-01), Adams et al.
patent: 5204325 (1993-04-01), Lindstrom et al.
patent: 5208219 (1993-05-01), Ogawa et al.
patent: 5356629 (1994-10-01), Sander et al.
patent: 5413989 (1995-05-01), Ogawa et al.
patent: 5801014 (1998-09-01), Lee et al.
patent: 6683064 (2004-01-01), Thompson et al.
Oxford Dictionary of Biochemistry and Molecular Biology, Oxford University Press, Oxford, 1997 pp. 125-126.
Hotten et al., “Recombinant Human Growth/Differentiation Factor 5 Stimulates Mesenchyme Aggregation and Chondrogenesis Responsible for the Skeletal Development of Limb”, Growth Factors, vol. 13, pp. 65-74, 1996.
Docherty et al., “Glycosaminoglycans Facilitate the Movement of Fibroblasts Through Three-Dimensional Collagen Matrtices”, Journal of Cell Science, vol. 92, pp. 263-270.
Hall & Miyake, “Divide, Accumulate, Differentiate: Cell Condensation in Skeletal Development Revisited”, International Journal of Development Biology, vol. 39, pp. 881-893, 1995.
Iwasaki et al., “Regulation of Proliferation and Osteochondrogenic Differentiation of Periosteum-deived Cells by Transforming Growth Factor-Beta and Basic Fibroblast Growth Factor”, Journal of Bone and Joint Surgery, vol. 77, (4), pp. 543-554, 1995.
Kawasaki et al., “Hyaluronic Acid Enhances Proliferation and Chondroitin Sulfate Synthesis in Cultured Chondrocytes Embedded in Collagen Gels”, Journal of Cellular Physiology, vol. 179, pp. 142-148, 1999.
PCT International Search Report, PCT/US99/24130, Feb. 8, 2000.
Heidaran et al., “Extracellular Matrix Modulation of rhGDF-5-Induced Cellular Differentiation”, e-biomed, vol. 2, Sep. 2000.
Massague, Joan, The TGF-β Family Growth and Differentiation Factors, Cell, vol. 49, No. 4, May 1987.
Daverman Robin
Heidaran Mohammad A.
Liu Lin-Shu
Spiro Robert C.
Beyer Weaver & Thomas LLP.
Depuy Spine, Inc.
Robinson Hope A.
Weber Jon
LandOfFree
Method of inducing or enhancing chondrogenesis with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inducing or enhancing chondrogenesis with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inducing or enhancing chondrogenesis with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3510829